Free Subscription

  • Access 15 free news articles each month

Professional

Try one month for $5
  • Unlimited access to news,insights and opinions
  • Quarterly and weekly magazines
  • Independent research reports and forecasts
  • Quarterly webinars with industry experts
  • Q&A with retail leaders
  • Career advice
  • Exclusive Masterclass access. Part of Retail Week 2021

Opinion: Here are the pros and cons of Wesfarmers’ API bid

Wesfarmers’ left-field bid for Australian Pharmaceutical Industries (API) is a somewhat risky investment move for the Perth-based conglomerate. On the plus side, the health sector has the growth potential that Wesfarmers wants to pursue and API could provide a platform on which Wesfarmers could build a health division. On the flip side, the acquisition of API would take Wesfarmers into a fragmented, highly government-regulated business sector against significant large competitors. Moreover, th